Hemodynamic Instability Clinical Trial
Official title:
Hemodynamic Effects of Low Dose Spinal Anesthesia for Cesarean Section
We propose to study the effects on hemodynamics (blood pressure, cardiac output, and central
venous pressure) of two doses of bupivacaine for spinal anesthesia during cesarean section:
a higher dose of 12 mg to a lower dose of 4.5 mg. We will examine recovery times, incidence
of hypotension, and compare pain control and maternal satisfaction during and after cesarean
section.
We hypothesize that low dose bupivacaine spinal anesthesia will provide equivalent
anesthesia for cesarean section compared to conventional dose bupivacaine, with less
hypotension, faster recovery time, and enhanced maternal satisfaction. Maternal satisfaction
will be assessed by self-reported pain scores, incidence of nausea and vomiting, shivering,
and ability to interact with baby in the OR.
Hypothesis
It is hypothesized that low dose spinal anesthesia can provide equivalent anesthesia for
cesarean section as higher conventional dose spinal anesthesia, with less hypotension,
faster recovery and enhanced maternal satisfaction.
Patient Population
Adult females having elective, repeat cesarean sections who have given informed consent.
Exclusion Criteria
- Contraindications to dural puncture
- BMI >40
- Elective C/S presenting in labour or with rupture of membranes
- Placenta previa or accrete
Methodology
Patients will be screened in the antenatal clinic at Women's Hospital, Health Sciences
Centre (HSC), Winnipeg during one of their regularly scheduled visits. If patients are
scheduled at another antenatal clinic in the city, we will ask the obstetrician to briefly
mention the study to potential study patients, and if they are interested give them the
consent form to take home and read. We will then phone patients, obtain verbal consent and
discuss any questions they may have. On the morning of their procedure we will obtain
written consent, and answer any additional questions they may have. Alternatively, patients
will be approached by their obstetrician in clinic, and if interested will be given the
option to go to the Pre-Anesthesia Clinic at HSC where a member of our study team will
discuss the study with them and obtain written consent.
Potential patients will be provided with information regarding the study and consent will be
obtained prior to their enrollment in the study. Forty patients will be randomized into two
groups: 1. Conventional dose spinal anesthesia 2. Low dose spinal anesthesia. Randomization
will occur via sealed envelope prior to their scheduled cesarean section. The patient will
be blinded to the randomization.
All women will have standard monitors. In addition, a radial arterial line will be inserted
for continuous blood pressure measurement and cardiac output measurements using the FloTrac
sensor and Vigileo monitor(cardiac output monitor using arterial waveform analysis, Edwards
Life Sciences). All women will receive a preload of 500ml of Ringers Lactate solution
intravenously.
The conventional dose control group will receive a spinal anesthetic consisting of
hyperbaric bupivacaine 1.2cc (9mg) with fentanyl 15mg and preservative free morphine 150mcg.
The patient will be in the sitting position for the dural puncture and then positioned
supine, in the left lateral tilt position after the anesthetic solution has been given. Once
block height has been established the patient will be placed in 20-30 degrees trendelenberg
for the cesarean section.
The low-dose spinal group will receive a spinal anesthetic consisting of hyperbaric
bupivacaine 4.5mg with fentanyl 15mg and preservative free morphine 150mcg. The patient will
be positioned on her side, right side down and head down 20-30 degrees for the dural
puncture and then positioned supine in the left lateral tilt position after the anesthetic
solution has been given. The OR table will be kept in 20-30 degrees head down for the
cesarean section.
Blood pressure will be monitored continuously. Cardiac output measurement will be done
immediately prior to administering the spinal and immediately after positioning in a left
lateral tilt position and then every five minutes until the end of the operation.
All women will be instructed in the use of a patient controlled analgesia (PCA) remifentanil
infusion which they can use during the cesarean section if they experience any discomfort.
If this is not adequate, 60-70% nitrous oxide will be attempted. If adequate pain control
cannot be established and the cesarean section is not near completion, conversion to a
general anesthetic will be the next step. All women will receive rectal naproxen at the
conclusion of the surgery unless there is a contraindication or bleeding is a concern. All
women will receive prophylactic ondansetron intraoperatively unless there is a
contraindication.
Decreases in mean blood pressure greater than 20% from baseline or less than 90 mm Hg will
be defined as hypotension and will be treated with incremental doses of phenylephrine
(50-100mcg IV) or ephedrine (5mg) if maternal heart rate is less than 60 bpm. A 500cc
lactated ringers bolus will be co-administered with initiation of the spinal anesthetic.
Further fluids will be administered with a goal of approximately 1-1.5 liters
intraoperatively. Each patient will in addition receive 20 units Oxytocin in 500cc saline.
Additional fluid or uterotonics will be given as necessary for bleeding or hypotension and
will be taken into account at the end.
Levels of sensory and motor blockade will be recorded just prior to skin prep, following
arrival in recovery room and then every 30 minutes thereafter. Sensory block will be
monitored by dermatome level at which there is a loss of sensation to ice. Motor blockade
will be checked using the modified Bromage score (0 = no impairment, 1 = unable to raise
extended legs but able to move knees and ankles, 2 = unable to raise extended legs or to
flex knees but able to move feet, 3 = unable to flex ankles, knees or hips).
Maternal satisfaction will be assessed as self reported pain scores, nausea/vomiting,
shivering, ability to interact with baby in the OR.
Outcome measures will include the following
1. Hemodynamics (BP, heart rate (HR), Cardiac Index)
2. Time to completion of spinal anesthetic (from skin puncture to positioning in the left
lateral tilt position)
3. Surgical time (skin incision to skin closure)
4. Total remifentanil administration during the procedure
5. Total phenylephrine administration during the procedure
6. Administration of any other sedatives/anti-emetics
7. Fetal cord blood gases (arterial and venous) and Apgar scores
8. Maternal satisfaction scores
9. Bilateral sensory block levels Bromage scores on arrival to PACU and every 30 minutes
until the patient is discharge ready
10. Time to being discharge ready from PACU
11. Complications (difficult spinal, PDPH)
Outcome 1 to 6 will be recorded intraoperatively (average time 90 to 120 minutes). Outcomes
6 to 10 will be recorded in the post anesthesia care unit (PACU)(average stay 4 to 6 hours).
Outcome 11 will be recorded for the duration of the patient's hospital stay.
Patients will be followed for the duration of their hospital stay (estimated three days).
Statistical Analysis
Statistical analysis will be done by the Biostatistical Consulting Unit of the University of
Manitoba. It will consist of analysis of variance for repeated measures for continuous
variables, student's T-test and Chi square analysis for non-parametric variables. P<0.05
will be considered statistically significant.
We propose to study 20 patients in each group.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor)
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03653910 -
Effect-site Concentration of Remifentanil for Double-lumen Tubes Intubation: Airtraq VS Macintosh Laryngoscope
|
N/A | |
Completed |
NCT06000098 -
Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
|
||
Recruiting |
NCT02565251 -
Volemic Resuscitation in Sepsis and Septic Shock
|
N/A | |
Terminated |
NCT02365688 -
Hemodynamic Response During Goal Directed Fluid Therapy in the OR
|
N/A | |
Completed |
NCT01605279 -
Dobutamine Versus Placebo for Low Superior Vena Cava Flow in Newborns
|
Phase 2 | |
Completed |
NCT01559675 -
Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery
|
N/A | |
Recruiting |
NCT04010058 -
Postoperative Continuous Non-invasive Haemodynamic Monitoring on the Ward
|
N/A | |
Completed |
NCT06268275 -
Comparison of Effects of Scalp Block and Intravenous Esmolol on Hemodynamic Response Following the Skull Pins Application for Elective Supratentorial Craniotomy
|
N/A | |
Recruiting |
NCT04926220 -
Dynamic Estimation of Cardiac Output in the Operating Room
|
||
Not yet recruiting |
NCT05003011 -
Correlation of Hemodynamics Via Pulmonary Artery Catherization and the Cardiospire
|
||
Completed |
NCT03599440 -
Effect of Extended Infusion Lines on Pulse Contour-based Measurements
|
||
Completed |
NCT05035485 -
Maternal Cardiac Output Response to Rescue Norepinephrine and Phenylephrine Boluses in Patients With Severe Preeclampsia
|
N/A | |
Not yet recruiting |
NCT04227821 -
Hemodynamic Optimalization in Pediatric Patients
|
||
Completed |
NCT05481047 -
Prevention or Treatment of Arterial Hypotension and Oxygen Cerebral Saturation During Major Abdominal Surgery
|
N/A | |
Completed |
NCT06158165 -
Evaluating The Cardiovascular Effects of Tourniquet Application
|
||
Not yet recruiting |
NCT04076709 -
Cardiovascular Effects of Muscle Relaxation During Laparoscopic Surgery
|
Phase 4 | |
Not yet recruiting |
NCT03828032 -
Multi-parameters'Change Process During Dehydration Therapy on Brain Edema Patients.
|
N/A | |
Completed |
NCT04089098 -
VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbility
|
||
Recruiting |
NCT05570682 -
Manually Controlled Infusion vs Target Controlled Infusion for StrokeThrombectomy
|
N/A | |
Completed |
NCT04574908 -
A Pilot Trial of Continuous Portable Postoperative Hemodynamic And Saturation Monitoring On Hospital Wards
|
N/A |